rs78198409
- chr8-86739620-GTTTTTT-G
- chr8-86739620-GTTTTTT-GT
- chr8-86739620-GTTTTTT-GTT
- chr8-86739620-GTTTTTT-GTTT
- chr8-86739620-GTTTTTT-GTTTT
- chr8-86739620-GTTTTTT-GTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTGTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTATATTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTCTGTCTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTGTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTATTTTTTTTTTTTCTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTATTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTCTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTATATTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTATTTTATTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTCTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTGTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTGTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTATTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr8-86739620-GTTTTTT-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_019098.5(CNGB3):c.211+29_211+34delAAAAAA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000147 in 1,360,262 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_019098.5 intron
Scores
Clinical Significance
Conservation
Publications
- achromatopsia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- CNGB3-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- achromatopsiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-childhood-onset retinal dystrophyInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_019098.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CNGB3 | TSL:1 MANE Select | c.211+29_211+34delAAAAAA | intron | N/A | ENSP00000316605.5 | Q9NQW8-1 | |||
| CNGB3-AS1 | TSL:3 | n.449-21215_449-21210delTTTTTT | intron | N/A | |||||
| CNGB3 | TSL:2 | n.193+29_193+34delAAAAAA | intron | N/A |
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome AF: 0.00000147 AC: 2AN: 1360262Hom.: 0 AF XY: 0.00000296 AC XY: 2AN XY: 676428 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 0
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at